104 related articles for article (PubMed ID: 10530769)
21. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Zhang X; D'Agostino J; Wu H; Zhang QY; von Weymarn L; Murphy SE; Ding X
J Pharmacol Exp Ther; 2007 Nov; 323(2):570-8. PubMed ID: 17671098
[TBL] [Abstract][Full Text] [Related]
22. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer?
Maser E
Trends Pharmacol Sci; 1997 Aug; 18(8):270-5. PubMed ID: 9277130
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes.
Collazo NR; Sultatos LG
Biochem Pharmacol; 1995 Nov; 50(11):1933-41. PubMed ID: 8615875
[TBL] [Abstract][Full Text] [Related]
24. Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes.
Jorquera R; Castonguay A; Schuller HM
Drug Metab Dispos; 1993; 21(2):318-24. PubMed ID: 8097703
[TBL] [Abstract][Full Text] [Related]
25. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
26. Absence of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by flavin-containing monooxygenase (FMO).
Lamoureux J; Castonguay A
Carcinogenesis; 1997 Oct; 18(10):1979-84. PubMed ID: 9364009
[TBL] [Abstract][Full Text] [Related]
27. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol.
Alfaidy N; Li W; MacIntosh T; Yang K; Challis J
J Clin Endocrinol Metab; 2003 Oct; 88(10):5033-8. PubMed ID: 14557491
[TBL] [Abstract][Full Text] [Related]
28. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
Maser E; Wsol V; Martin HJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
[TBL] [Abstract][Full Text] [Related]
29. Human 11beta-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form.
Blum A; Martin HJ; Maser E
Biochem Biophys Res Commun; 2000 Sep; 276(2):428-34. PubMed ID: 11027492
[TBL] [Abstract][Full Text] [Related]
30. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
31. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: additional domains for membrane attachment?
Blum A; Raum A; Martin H; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):749-59. PubMed ID: 11306091
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
33. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Ge RS; Gao HB; Nacharaju VL; Gunsalus GL; Hardy MP
Endocrinology; 1997 Jun; 138(6):2435-42. PubMed ID: 9165033
[TBL] [Abstract][Full Text] [Related]
34. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
Stambergova H; Skarydova L; Dunford JE; Wsol V
Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
[TBL] [Abstract][Full Text] [Related]
35. 11
Yang X; Hua W; Ryu S; Yates P; Chang C; Zhang H; Di L
Drug Metab Dispos; 2018 Jul; 46(7):1023-1029. PubMed ID: 29674492
[TBL] [Abstract][Full Text] [Related]
36. 11beta-hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells.
Leckie CM; Welberg LA; Seckl JR
J Endocrinol; 1998 Nov; 159(2):233-8. PubMed ID: 9795363
[TBL] [Abstract][Full Text] [Related]
37. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.
Bland R; Worker CA; Noble BS; Eyre LJ; Bujalska IJ; Sheppard MC; Stewart PM; Hewison M
J Endocrinol; 1999 Jun; 161(3):455-64. PubMed ID: 10333548
[TBL] [Abstract][Full Text] [Related]
38. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats.
Staretz ME; Koenig LA; Hecht SS
Carcinogenesis; 1997 Sep; 18(9):1715-22. PubMed ID: 9328166
[TBL] [Abstract][Full Text] [Related]
39. Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.
Stulnig TM; Oppermann U; Steffensen KR; Schuster GU; Gustafsson JA
Diabetes; 2002 Aug; 51(8):2426-33. PubMed ID: 12145154
[TBL] [Abstract][Full Text] [Related]
40. 11beta-Hydroxysteroid dehydrogenase type 2 in the rat corpus luteum: induction of messenger ribonucleic acid expression and bioactivity coincident with luteal regression.
Waddell BJ; Benediktsson R; Seckl JR
Endocrinology; 1996 Dec; 137(12):5386-91. PubMed ID: 8940361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
